Legislation Details

File #: RES-2023-841    Version: 1
Type: Resolution Status: Passed
File created: 10/26/2023 In control: Board of County Commissioners
On agenda: 11/15/2023 Final action: 11/15/2023
Title: RE: Insulin Lawsuit Presentation-Mike Behm
Attachments: 1. Insulin Presentation
To: Board of County Commissioners

From: Joshua Freeman, Director of Administration

title
RE: Insulin Lawsuit Presentation-Mike Behm

recommendation
BOARD ACTION REQUESTED:

BACKGROUND:

DISCUSSION:

IMPACT ON HUMAN RESOURCES:

IMPACT ON BUDGET:

IMPACT ON FACILITIES:

IMPACT ON TECHNOLOGY:

CONFORMITY TO COUNTY PRIORITIES:











resolution
TO THE HONORABLE CHAIRPERSON AND MEMBERS OF THE GENESEE COUNTY BOARD OF COMMISSIONERS, GENESEE COUNTY, MICHIGAN
LADIES AND GENTLEMEN:
WHEREAS, the Genesee County Board of County Commissioners ("this Board") is the policy-making body of the County; and
WHEREAS, this Board has the authority to take action to protect the public health, safety, and welfare of the citizens of Genesee County; and
WHEREAS, for the past several years, there has been a class action lawsuit filed on behalf of consumers of insulin, insulin-analog, and other diabetes medications against insulin manufacturers and the three largest pharmacy benefit managers alleging that they have colluded to artificially inflate the price of diabetes medication; and
WHEREAS, the Board of County Commissioners may sue to obtain any money due to the County; and
WHEREAS, because Genesee County has provided, currently provides, and will continue to provide pharmaceutical benefits coverage for its employees and retirees through a self-funded third-party administrator, a lawsuit against these defendants may be successful in recovering these alleged overcharges; and
WHEREAS, the residents of Genesee County will benefit from the retention of special outside counsel to investigate and pursue, if appropriate, County claims against insulin manufacturers and pharmacy benefit managers who allegedly colluded to artificially inflate the price of diabetes medication, on a contingent fee basis, wherein there is no attorney fee or reimbursement of litigation expenses if there is no recovery; and
WHEREAS, this Board currently is represented by Wei...

Click here for full text